Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — Mati Therapeutics Inc.

0001574251-26-000001 · filed Jul 2, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$4,896,500
Reported amount sold
$2,649,815
Minimum investment
$0
Investors
2
Sales commission
$0
Finders' fees
$0

Issuer

Name
Mati Therapeutics Inc.
CIK
1574251
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
101 Colorado Street
AUSTIN, TX 78701
Phone
512-720-1333

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗